In NSCLC, PD‐L1 is activated by deregulation of the ZEB1/miR‐200 axis in more mesenchymal cells (Chen et al, 2014; Jung et al, 2020). The gene discussed is ZEB1; the disease is non-small cell lung carcinoma.